# Jefferies Financial Group Inc.: financial statements, quarterly

JEF · NYSE · CIK 96223 · [Financials](/sectors/financials.md) · fiscal year ends Nov 30

Pages: [Overview](/companies/jef.md) · [Financials](/companies/jef/financials.md) · [Filings](/companies/jef/filings.md) · [Insiders](/companies/jef/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/jef/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-11-30) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | Q4 FY2024 (2024-11-30) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | Q4 FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [860 d](/filings/0000096223-26-000009.md) | [1,035](/filings/0001628280-25-017192.md) | [1,094](/filings/0000096223-25-000007.md) | [1,284](/filings/0000096223-25-000014.md) | [1,445 d](/filings/0000096223-26-000009.md) | [1,144](/filings/0000096223-26-000017.md) | [1,227](/filings/0000096223-26-000025.md) | [1,504](/filings/0000096223-26-000033.md) | [1,671 d](/filings/0000096223-26-000009.md) | [1,456](/filings/0000096223-26-000017.md) | [1,675](/filings/0000096223-26-000025.md) | [1,752](/filings/0000096223-26-000033.md) |
| Cost of revenue | $m | [23.3 d](/filings/0000096223-26-000009.md) | [34.7](/filings/0001628280-25-017192.md) | [37.5](/filings/0000096223-25-000007.md) | [37.4](/filings/0000096223-25-000014.md) | [96.8 d](/filings/0000096223-26-000009.md) | [41.6](/filings/0000096223-26-000017.md) | [43.0](/filings/0000096223-26-000025.md) | [34.4](/filings/0000096223-26-000033.md) | [72.0 d](/filings/0000096223-26-000009.md) | [29.9](/filings/0000096223-26-000017.md) | [31.3](/filings/0000096223-26-000025.md) | [22.9](/filings/0000096223-26-000033.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [772 d](/filings/0000096223-24-000006.md) | [814](/filings/0000096223-24-000015.md) | [860](/filings/0000096223-24-000024.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [16.8 d](/filings/0000096223-26-000009.md) | [56.0](/filings/0001628280-25-017192.md) | [73.1](/filings/0000096223-25-000007.md) | [78.0](/filings/0000096223-25-000014.md) | [86.1 d](/filings/0000096223-26-000009.md) | [14.2](/filings/0000096223-26-000017.md) | [43.5](/filings/0000096223-26-000025.md) | [89.3](/filings/0000096223-26-000033.md) | [37.5 d](/filings/0000096223-26-000009.md) | [52.9](/filings/0000096223-26-000017.md) | [65.6](/filings/0000096223-26-000025.md) | [62.8](/filings/0000096223-26-000033.md) |
| Net income | $m | [58.7 d](/filings/0000096223-26-000009.md) | [156](/filings/0001628280-25-017192.md) | [155](/filings/0000096223-25-000007.md) | [181](/filings/0000096223-25-000014.md) | [224 d](/filings/0000096223-26-000009.md) | [137](/filings/0000096223-26-000017.md) | [91.4](/filings/0000096223-26-000025.md) | [243](/filings/0000096223-26-000033.md) | [211 d](/filings/0000096223-26-000009.md) | [159](/filings/0000096223-26-000017.md) | [250](/filings/0000096223-26-000025.md) | [288](/filings/0000096223-26-000033.md) |
| Diluted EPS | $ per share | not reported | [0.66](/filings/0001628280-25-017192.md) | [0.64](/filings/0000096223-25-000007.md) | [0.75](/filings/0000096223-25-000014.md) | not reported | [0.57](/filings/0000096223-26-000017.md) | [0.40](/filings/0000096223-26-000025.md) | [1.01](/filings/0000096223-26-000033.md) | not reported | [0.70](/filings/0000096223-26-000017.md) | not reported | not reported |
| Basic EPS | $ per share | not reported | [0.68](/filings/0001628280-25-017192.md) | [0.66](/filings/0000096223-25-000007.md) | [0.78](/filings/0000096223-25-000014.md) | not reported | [0.60](/filings/0000096223-26-000017.md) | [0.41](/filings/0000096223-26-000025.md) | [1.04](/filings/0000096223-26-000033.md) | not reported | [0.72](/filings/0000096223-26-000017.md) | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-11-30) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | FY2024 (2024-11-30) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [8.5](/filings/0001628280-25-002833.md) | [7.6](/filings/0000096223-24-000015.md) | [10.8](/filings/0000096223-24-000024.md) | [10.6](/filings/0001628280-24-042612.md) | [12.2](/filings/0000096223-26-000009.md) | [11.2](/filings/0001628280-25-017192.md) | [11.3](/filings/0000096223-25-000007.md) | [11.5](/filings/0000096223-25-000014.md) | [14.0](/filings/0000096223-26-000033.md) | [12.0](/filings/0000096223-26-000017.md) | [14.3](/filings/0000096223-26-000025.md) | [16.9](/filings/0000096223-26-000033.md) |
| Current assets | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [57.9](/filings/0001628280-25-002833.md) | [60.9](/filings/0000096223-24-000015.md) | [63.0](/filings/0000096223-24-000024.md) | [63.3](/filings/0001628280-24-042612.md) | [64.4](/filings/0000096223-26-000009.md) | [70.2](/filings/0001628280-25-017192.md) | [67.3](/filings/0000096223-25-000007.md) | [69.3](/filings/0000096223-25-000014.md) | [76.0](/filings/0000096223-26-000033.md) | [74.4](/filings/0000096223-26-000017.md) | [79.5](/filings/0000096223-26-000025.md) | [81.3](/filings/0000096223-26-000033.md) |
| Current liabilities | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $bn | [48.1](/filings/0001628280-25-002833.md) | [51.1](/filings/0000096223-24-000015.md) | [53.0](/filings/0000096223-24-000024.md) | [53.2](/filings/0001628280-24-042612.md) | [54.1](/filings/0000096223-26-000009.md) | [60.0](/filings/0001628280-25-017192.md) | [56.9](/filings/0000096223-25-000007.md) | [58.8](/filings/0000096223-25-000014.md) | [65.4](/filings/0000096223-26-000033.md) | [63.7](/filings/0000096223-26-000017.md) | [68.9](/filings/0000096223-26-000025.md) | [70.5](/filings/0000096223-26-000033.md) |
| Long-term debt | $bn | [9.7](/filings/0001628280-25-002833.md) | [9.9](/filings/0000096223-24-000015.md) | [12.7](/filings/0000096223-24-000024.md) | [12.9](/filings/0001628280-24-042612.md) | [13.5](/filings/0000096223-26-000009.md) | [14.8](/filings/0001628280-25-017192.md) | [15.4](/filings/0000096223-25-000007.md) | [16.0](/filings/0000096223-25-000014.md) | [15.9](/filings/0000096223-26-000033.md) | [17.2](/filings/0000096223-26-000017.md) | [18.0](/filings/0000096223-26-000025.md) | [18.5](/filings/0000096223-26-000033.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [1.0](/filings/0001628280-25-002833.md) | [1.3](/filings/0000096223-24-000015.md) | [1.6](/filings/0000096223-24-000024.md) | [1.7](/filings/0001628280-24-042612.md) | [0.4](/filings/0000096223-26-000009.md) | [1.2](/filings/0001628280-25-017192.md) | [1.3](/filings/0000096223-25-000007.md) | [1.2](/filings/0000096223-25-000014.md) | [1.8](/filings/0000096223-26-000017.md) | [1.9](/filings/0000096223-26-000017.md) | not reported | not reported |
| Shareholders' equity | $bn | [9.7](/filings/0001628280-25-002833.md) | [9.8](/filings/0000096223-24-000015.md) | [9.9](/filings/0000096223-24-000024.md) | [10.0](/filings/0001628280-24-042612.md) | [10.2](/filings/0000096223-26-000009.md) | [10.2](/filings/0001628280-25-017192.md) | [10.3](/filings/0000096223-25-000007.md) | [10.4](/filings/0000096223-25-000014.md) | [10.6](/filings/0000096223-26-000033.md) | [10.6](/filings/0000096223-26-000017.md) | [10.6](/filings/0000096223-26-000025.md) | [10.7](/filings/0000096223-26-000033.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: not reported
- Total assets: us-gaap:Assets
- Current liabilities: not reported
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-11-30) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | Q4 FY2024 (2024-11-30) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | Q4 FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(43.7) d](/filings/0000096223-24-000006.md) | [(1,258)](/filings/0001628280-25-017192.md) | [77.6 d](/filings/0000096223-25-000007.md) | [(670) d](/filings/0000096223-25-000014.md) | [1,710 d](/filings/0000096223-26-000009.md) | [(2,665)](/filings/0000096223-26-000017.md) | [(978) d](/filings/0000096223-26-000025.md) | [184 d](/filings/0000096223-26-000033.md) | [1,964 d](/filings/0000096223-26-000009.md) | [(1,737)](/filings/0000096223-26-000017.md) | [1,599 d](/filings/0000096223-26-000025.md) | [2,591 d](/filings/0000096223-26-000033.md) |
| Capital expenditure | $m | [(79.1) d](/filings/0000096223-26-000009.md) | [96.2](/filings/0001628280-25-017192.md) | [48.6 d](/filings/0000096223-25-000007.md) | [35.8 d](/filings/0000096223-25-000014.md) | [69.9 d](/filings/0000096223-26-000009.md) | [49.6](/filings/0000096223-26-000017.md) | [43.7 d](/filings/0000096223-26-000025.md) | [58.2 d](/filings/0000096223-26-000033.md) | [56.0 d](/filings/0000096223-26-000009.md) | [64.9](/filings/0000096223-26-000017.md) | [48.0 d](/filings/0000096223-26-000025.md) | [49.3 d](/filings/0000096223-26-000033.md) |
| Dividends paid | $m | [70.0 d](/filings/0000096223-26-000009.md) | [69.9](/filings/0001628280-25-017192.md) | [69.9 d](/filings/0000096223-25-000007.md) | [81.6 d](/filings/0000096223-25-000014.md) | [81.6 d](/filings/0000096223-26-000009.md) | [92.7](/filings/0000096223-26-000017.md) | [94.3 d](/filings/0000096223-26-000025.md) | [93.5 d](/filings/0000096223-26-000033.md) | [93.5 d](/filings/0000096223-26-000009.md) | [92.8](/filings/0000096223-26-000017.md) | [91.8 d](/filings/0000096223-26-000025.md) | [91.9 d](/filings/0000096223-26-000033.md) |
| Share repurchases | $m | [4.1 d](/filings/0000096223-26-000009.md) | [43.0](/filings/0001628280-25-017192.md) | [0.9 d](/filings/0000096223-25-000007.md) | [0.3 d](/filings/0000096223-25-000014.md) | [0.0 d](/filings/0000096223-26-000009.md) | [56.3](/filings/0000096223-26-000017.md) | [1.3 d](/filings/0000096223-26-000025.md) | [0.9 d](/filings/0000096223-26-000033.md) | [0.0 d](/filings/0000096223-26-000009.md) | [174](/filings/0000096223-26-000017.md) | [197 d](/filings/0000096223-26-000025.md) | [68.2 d](/filings/0000096223-26-000033.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities, us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-05-31) | Q3 FY2022 (2022-08-31) | Q1 FY2023 (2023-02-28) | Q2 FY2023 (2023-05-31) | Q3 FY2023 (2023-08-31) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | Q1 FY2026 (2026-02-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [252](/filings/0000096223-23-000026.md) | [251](/filings/0000096223-23-000033.md) | [248](/filings/0000096223-24-000015.md) | [245](/filings/0000096223-24-000024.md) | [232](/filings/0001628280-24-042612.md) | [225](/filings/0001628280-25-017192.md) | [226](/filings/0000096223-25-000007.md) | [222](/filings/0000096223-25-000014.md) | [222](/filings/0000096223-26-000017.md) | [222](/filings/0000096223-26-000025.md) | [223](/filings/0000096223-26-000033.md) | [223](/filings/0000096223-26-000017.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 204,432,307 at 2026-03-30, from the cover of the [10-Q filed 2026-04-07](/filings/0000096223-26-000017.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.
